Based on Your Reading:
Get Your Free Mesothelioma Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Papillary mesothelioma, also called well-differentiated papillary mesothelioma, is a rare subtype of epithelial mesothelioma. Well-differentiated papillary mesothelioma affects the lining of the abdomen (peritoneum), the lining of the lungs (pleura) and the lining of the testes (tunica vaginalis).
Written by Karen Selby, RN | Medically Reviewed By Dr. Rupesh Kotecha | Edited By Walter Pacheco | Last Update: June 27, 2024
The majority of well-differentiated papillary mesothelioma (WDPM) tumors develop in women and grow in the abdominal cavity.
Doctors have found WDPMT tumor growth on several of the body’s protective membranes, including the pleura (lining of the lungs), pericardium (heart sac) and tunica vaginalis (lining of the testes).
From a medical standpoint, these tumors are benign. Some cases have turned into malignant mesothelioma over time, but the chance of this happening is unlikely. Some people with WDPMT have also experienced several recurrences after treatment.
Solid papillary mesothelioma tumors are benign or very low-grade tumors. Differentiating from malignant mesotheliomas is essential. A 2021 research report in Modern Pathology reported this stance.
Researchers are unsure if asbestos exposure causes this tumor. Some patients have a history of asbestos exposure, but most do not. The cause of this disease remains.
About 50 cases of WDPMT in the peritoneum exist in the medical literature. A 2019 study published in Annals of Surgical Oncology reported this data. There are also several small case reports of WDPM of the pleura. About 20 documented cases of testicular papillary mesothelioma exist.
Get Your Free Mesothelioma Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Many cases of well-differentiated papillary mesothelioma tumors have no symptoms. The disease causes pain and excessive fluid buildup in some patients.
WDPMT of the tunica vaginalis can cause scrotal swelling or the formation of testicular lumps. In one study of 22 WDPMT cases, only two patients reported symptoms to their doctors. One patient experienced acute abdominal pain, and the other had chronic pelvic pain.
Doctors must collect a comprehensive tumor sample to prevent misdiagnosis. The only definitive procedure for diagnosing WDPM and other mesotheliomas is a biopsy, which collects a tissue sample for laboratory analysis.
While looking for signs of mesothelioma, doctors also look for negative markers. These markers signal that the tumor is likely not mesothelioma but another type of cancer. For example, mesothelioma patients rarely test positive for the PAX8 protein. If it’s detected, this could signal kidney cancer, thyroid cancer and cancers of the female reproductive system.
Doctors usually discover this condition during an unrelated pelvic or abdominal surgery. An imaging test, such as a CT scan, may find it. However, this technique isn’t sensitive enough to detect tumors smaller than 1 centimeter.
Doctors have yet to reach a consensus on the most effective course of treatment.
Therapy usually involves a combination of the main types of mesothelioma treatment. These include surgery, chemotherapy and radiation therapy. Treatment options also depend on where the papillary mesothelioma tumors form.
A combination of surgery and heated chemotherapy treats abdominal cases. In a 2019 Annals of Surgical Oncology study, 37 of the 56 patients received this combination.
Learn about your diagnosis, top doctors and how to pay for treatment.
Get Your Free GuideThe outlook is better than the prognosis of patients with most other mesothelioma cell types.
WDPMT of the Pleura | WDPMT of the Peritoneum |
---|---|
6 years and 2 months | 12 years |
Only 5% to 10% of malignant mesothelioma patients survive five years after diagnosis. Several patients with WDPMT have survived for decades.
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Selby, K. (2024, June 27). Papillary Mesothelioma. Asbestos.com. Retrieved November 20, 2024, from https://www.asbestos.com/mesothelioma/papillary/
Selby, Karen. "Papillary Mesothelioma." Asbestos.com, 27 Jun 2024, https://www.asbestos.com/mesothelioma/papillary/.
Selby, Karen. "Papillary Mesothelioma." Asbestos.com. Last modified June 27, 2024. https://www.asbestos.com/mesothelioma/papillary/.
A medical doctor who specializes in mesothelioma or cancer treatment reviewed the content on this page to ensure it meets current medical standards and accuracy.
Please read our editorial guidelines to learn more about our content creation and review process.
Dr. Rupesh Kotecha is a renowned radiation oncologist in leadership roles at Miami Cancer Institute. He is an associate professor at Florida International University's college of medicine and an adjunct faculty member at Memorial Sloan Kettering.
Mesothelioma Center - Vital Services for Cancer Patients & Families doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.